WESTMINSTER, Colo., Sept. 13 /PRNewswire/ — GHX has renamed Healthcare Products Information Services (HPIS) as GHX Market Intelligence, which will operate as a business unit within the company, offering strategic decision-making data to healthcare manufacturers. HPIS was acquired in 2006 as part of GHX’s merger with Neoforma.
GHX Market Intelligence provides reports on distributed healthcare product sales, which manufacturers utilize to make more informed business decisions. Through its partnerships with more than 20 distributors and its exclusive relationship with the Health Industry Distributors Association (HIDA), GHX Market Intelligence obtains and analyzes an estimated 80 percent of all sales transaction data on distributed healthcare products in the U.S. across seven key healthcare market segments: hospital, physician, home health care, clinical laboratory, nursing homes/long-term care facilities, treatment centers, and other, which includes public health and physical therapy.
“Our exclusive relationship with HIDA provides us with the most complete, accurate, and timely source data for distributed healthcare product sales,” says Patrick McCarthy, Executive Vice President, GHX Business Intelligence Solutions. “As a result, we can offer customers the highest quality, decision-making information available to healthcare manufacturers.”
GHX Market Intelligence summarizes product-level sales by market segment with geographic specificity down to a three-digit zip code. With access to reliable, timely, and comprehensive data comprising a large percentage of the monthly transactions industry-wide, GHX Market Intelligence can extrapolate the data to project 100 percent of sales through the domestic medical-surgical and clinical-lab distribution supply chain. This market visibility allows GHX customers to target areas of growth and more effectively focus marketing, sales, business development, and product development efforts.
Most recently, GHX Market Intelligence began offering a series of syndicated market intelligence reports, called Executive Insight, to specifically meet the needs of smaller medical and surgical manufacturers. Larger manufacturers can also utilize the reports when introducing new products or researching new market segments. Executive Insight provides data and analysis on the following:
* Class by Major Report -- How a particular class of product, such as gloves or needles and syringes, is selling in each market segment * Major by Market Segment Report -- How an individual product is selling in a particular Market Segment * Manufacturer Trending Report -- Sales performance for a particular manufacturer in each of the top ten major product classes, e.g., gloves, skin care products, and by market segment * New Products Report -- The top 100 new products sold in the past four quarters in the hospital, long term care, and home health care market segments.
“GHX is a well-established and trusted name in the healthcare industry,” explains McCarthy. “Bringing HPIS under the GHX name demonstrates our commitment to this important service offering and clearly expresses to our customers the confidence we have in this timely, insightful and actionable business intelligence.”
About GHX
GHX empowers healthcare organizations to reduce costs and improve margins. This is achieved by delivering tools and services that automate processes and increase knowledge-based decision making. Service offerings include:
* Exchange services that support trading partner connectivity and provide electronic transaction sets, order validation and reporting tools * Content services utilizing the GHX AllSource(R) product content repository as the foundation for data synchronization and advanced content services * Contract services that maximize contract utilization * Procurement services that enable automation of the requisitioning process * Business Intelligence reports designed to provide strategic decision- making data * Pharmaceutical business solutions allowing manufacturers to gain control over rebate and contract management processes * Sales force automation services that allow healthcare manufacturers to streamline field sales processes and improve staff efficiencies
Through these services, healthcare providers and suppliers can improve efficiencies, automate processes and reduce operating expenses. Equity owners of GHX are Abbott Exchange, Inc.; AmerisourceBergen Corp.; Baxter Healthcare Corp.; B Braun Medical Inc.; Becton, Dickinson & Co.; Boston Scientific Corp.; Cardinal Health, Inc.; C.R. Bard, Inc.; Fisher Scientific International, Inc.; GE Healthcare; HCA; Johnson & Johnson Health Care Systems Inc.; McKesson Corp.; Medtronic USA, Inc.; Owens & Minor; Premier, Inc.; Siemens; Tyco Healthcare Group, LP; University HealthSystem Consortium; and VHA Inc. For more information, visit http://www.ghx.com/.
GHX
CONTACT: Karen Conway of GHX, cell, +1-303-564-2147, or +1-720-887-7215,or +1-719-488-0359, [email protected]
Web site: http://www.ghx.com/
Comments